Authors
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
New Developments in Neoadjuvant Therapy for Lung CancerIn this article, we review the new developments in neoadjuvant therapy for lung cancer.
Latest:
Novel Targets and Precision Medicine for Prostate Cancer-Part 2: Tumor Profiling and Personalized Therapy in Patients With Castration-Resistant Prostate CancerIn this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
A Patient With Pure Teratoma of the Testis Presenting With an Anterior Mediastinal MassA 39-year-old man is diagnosed with pure post-pubertal teratoma of the testis. What are the best steps of management?
Latest:
Newly Diagnosed Glioblastoma: A Review on Clinical ManagementThis review focuses on clinical developments and management of newly diagnosed glioblastoma, and includes a discussion about the incorporation of molecular features into the classification of this disease.
Latest:
Role of Chemopreventive Agents in Women at Increased Risk for Breast CancerCancer Network spoke with Charles Shapiro, MD, about the USPSTF's stance on use of tamoxifen, raloxifene, and aromatase inhibitors to prevent breast cancer.
Latest:
Regorafenib for Metastatic Colorectal Cancer: Common Toxicities and Prevention StrategiesAn oncology pharmacist discusses how to prevent and treat the toxicities from regorafenib for the treatment of colorectal cancer.
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
Multiple Myeloma With Extramedullary Disease: A Challenging Clinical DilemmaA 39-year-old woman with no significant medical history presented to the emergency department with progressive diffuse abdominal pain, involuntary weight loss, anemic syndrome, and limitation of mobility. What is the best treatment course to follow?
Latest:
What to Do When Anti–PD-1 Therapy Fails in Patients With MelanomaThis review summarizes the current available treatment strategies for patients with advanced melanoma when PD-1–directed therapy is not enough.
Latest:
Targeted Therapy for Mutation-Driven Metastatic Non–Small-Cell Lung Cancer: Considerations for ALK-Rearranged TumorsIn this article, important concepts in the molecular testing of non–small-cell lung cancer are highlighted.
Latest:
Looking to Agriculture Strategies to Manage Drug Resistance in CancerCancer Network spoke with Carlo Maley, PhD, about how strategies utilized in agriculture can be applied to drug resistance in oncology.
Latest:
Targeting the Metastatic Tumor Microenvironment to Limit Cancer ProgressionCancer Network spoke with Sheila A. Stewart, PhD, on how age-related changes in the tumor microenvironment may impact progression and metastasis.
Latest:
Favorable Results Seen With APX005M in Combination Therapy for Metastatic Ductal Pancreatic AdenocarcinomaCancer Network spoke with Mark H. O'Hara, MD, about the safety and efficacy of APX005M in combination with standard chemotherapy with or without nivolumab.
Latest:
Does Tumor Biology Play a Role in Colon Cancer Racial Disparities?Cancer Network spoke with Jennie Williams, PhD, and Jenny Paredes, a PhD student, about how tumor biology impacts chemotherapy response in African American vs Caucasian patients.
Latest:
Breast Cancer Screening Can Begin Later in Childhood Cancer SurvivorsResearch evaluated whether initiating breast cancer screening at age 30 may be preferable to current guidelines among survivors of childhood cancer with a history of chest irradiation.
Latest:
Dr. Schmidt on AMAROS Trial Results: Radiotherapy vs Surgery of the Axilla in Breast CancerCancer Network spoke with Hank Schmidt, MD, about the 10-year follow-up results of the EORTC AMAROS trial of radiotherapy vs surgery of the axilla in breast cancer patients with a positive sentinel node.
Latest:
CheckMate 204: New First-Line Therapy for Asymptomatic Melanoma Brain Metastases?The results of the phase II trial examining combination immunotherapy were presented during the ASCO 2019 meeting.
Latest:
Oncologists Reflect on Pandemic's Lasting Impact on Cancer CareHear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.
Latest:
Non–Small-Cell Lung Cancer After Mantle Radiation: A Case Report and Brief ReviewIn this case report, we present a non-Hodgkin lymphoma survivor who was incidentally found to have non–small-cell lung cancer 30 years after undergoing treatment that included mantle radiation. We discuss the treatment-related risk factors for lung cancer in this population and potential implications for long-term follow-up.
Latest:
The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate CancerThis case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate CancerThis case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?
Latest:
When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation TherapyThis review summarizes the current evidence supporting the use of SBRT as treatment for inoperable renal cell carcinoma, as well as provides recommendations for patient selection and reviews the technical aspects of treatment and the expected toxicities.
Latest:
Overcoming Physical and Social Barriers in the Lymphoma FieldLeaders from the lymphoma space highlight the importance of mentorship in establishing their careers and impart advice to women looking to advance theirs.
